Accelerate Immunotherapy Development with HLA‑A*0201 Restricted Epitope – Fast, GMP‑Grade, Risk‑Free
Targeted researchers, CROs, and biotech procurement managers who need high‑purity HLA‑A*0201 restricted epitope for T‑cell assays, vaccine design, and clinical‑grade studies.
Get Free Quote in 24 h
Why Your Current Epitope Supply Is Holding Back Projects
High price, low quality, slow delivery, and expensive shipping are the four most cited frustrations among US‑based biotech firms when sourcing HLA‑A*0201 restricted epitopes.
- Cost Overruns: Average market price for a 5 mg GMP‑grade epitope exceeds $2,500, inflating R&D budgets by up to 30 %.
- Quality Gaps: Non‑GMP suppliers often deliver ≤ 85 % purity, causing assay variability and repeat experiments.
- Delivery Delays: Typical lead times of 4–6 weeks clash with fast‑track clinical timelines.
- Logistics Costs: International freight from China can add $300‑$500 per batch, eroding cost advantages.
Imagine a scenario where a Phase I trial is delayed because the epitope batch failed QC. Every day of delay can cost sponsors $150,000+ in lost opportunity.
Discover the solution that eliminates these risks →
Our Competitive Edge: HLA‑A*0201 Restricted Epitope Made Simple
Global Technology Co., Ltd leverages a powerful factory network, stringent quality assurance, and OEM/ODM design flexibility to deliver high‑purity, GMP‑certified HLA‑A*0201 restricted epitopes at a fraction of the market price.
Core Advantages (Long‑Tail Keywords Integrated)
- Custom HLA‑A*0201 epitope synthesis: Tailor length (8‑20 aa), modifications, and carrier conjugates.
- HLA‑A*0201 epitope for cancer vaccine: GMP‑grade, endotoxin < 0.5 EU/mg, ready for IND filing.
- Bulk HLA‑A*0201 peptide production: Scalable from 10 mg to 5 kg with consistent batch‑to‑batch purity ≥ 98 %.
- HLA‑A*0201 immunotherapy research support: Free analytical data package (HPLC, MS, CD‑spectra).
Technical Specifications
| Parameter |
Specification |
| Sequence |
Custom (8‑20 aa) – HLA‑A*0201 anchor residues |
| Purity |
≥ 98 % (HPLC), ≥ 99 % (LC‑MS) |
| Scale |
10 mg – 5 kg per order |
| GMP Compliance |
ISO 9001, GMP, FDA‑registered facility |
| Stability |
-20 °C, 24 months (dry powder) |
| Packaging |
Vacuum‑sealed, amber glass vials, optional lyophilized format |
Application Scenarios & Case Studies
Case 1 – Neoantigen Vaccine Development (USA, 2025)
- Client needed 1 g of HLA‑A*0201 restricted epitope with > 99 % purity for GMP‑manufacturing.
- Delivery: 14 days (vs. 45 days typical).
- Result: Accelerated IND submission by 6 weeks, saving $450,000 in development costs.
Case 2 – High‑Throughput T‑Cell Screening (Canada, 2024)
- Custom library of 96 epitopes, each 10 mg, $0.12 per µg – 40 % cheaper than competitor.
- Assay reproducibility improved from CV 12 % to CV 3 % after switching to our GMP grade peptide.
See who trusts us →
Trusted by Industry Leaders
Testimonials
“The purity of the HLA‑A*0201 epitope from Global Technology allowed us to pass QC on the first run. Delivery was 2 weeks faster than any other supplier we tried.” – Dr. Michael Lee, VP R&D, ImmunoGenics (USA)
“Cost per milligram dropped by 35 % without compromising quality, enabling us to expand our neoantigen pipeline.” – Sarah Patel, Procurement Manager, BioNova Therapeutics (Canada)
Compliance & Certifications
- CE, FDA, ISO 9001, GMP, DMF, GMP‑certified cleanroom (Class 100)
- RoHS, FCC, GS, CB, VDE, SAA, HACCP/GMP, IPPC
Got questions? Find answers below →
Frequently Asked Questions
What is the typical lead time for a custom HLA‑A*0201 restricted epitope?
Standard synthesis (≤ 20 aa) is 10‑14 business days. For bulk orders (> 500 g) we guarantee 21 days with express freight.
Can you provide certificates of analysis (CoA) and GMP batch records?
Yes. Every batch ships with a detailed CoA, GMP batch record, and an independent third‑party analytical report (HPLC, MS, endotoxin).
Do you offer OEM/ODM design services for epitope conjugates?
Absolutely. Our R&D team can design carrier‑linked peptides, fluorescent tags, or lipid‑based formulations. Pricing is transparent and starts at $0.08 per µg.

What logistics options are available for US customers?
We partner with DHL, UPS, and FedEx. For urgent orders we provide express air freight (< 48 h) at a flat $120 surcharge. All shipments are fully customs‑cleared with INCOTERMS DDP.
Is after‑sales technical support included?
Yes. Our scientists provide free assay‑validation assistance for the first 30 days post‑delivery, plus a 12‑month warranty on peptide stability.
Ready to place an order? →
Start Your Project Today – Limited Stock, Zero Risk
Special Offer (Ends 30 days): Free 5 mg sample of any HLA‑A*0201 restricted epitope + Money‑Back Guarantee if purity < 98 %.
Request Free Sample & Quote
All transactions comply with US import regulations, FDA labeling requirements, and INCOTERMS DDP.
What Our Clients Say
“The turnaround time saved us months of delay. The peptide purity was spot‑on, and the technical support helped us optimize our ELISPOT assay.” – James O’Neil, Operations Manager, NovaCell (USA)
“Transparent pricing and free sample allowed us to compare before committing. We’re now a repeat buyer for all our HLA‑A*0201 epitope needs.” – Linda Gomez, Procurement Lead, MedTech Solutions (USA)
“Their OEM design service turned a simple peptide into a stable, lyophilized vaccine candidate in under two weeks.” – Dr. Alexei Morozov, Chief Scientist, ImmunoLab (USA)
About the Author
Dr. Emily Chen, Ph.D.
Senior Immunology Consultant, Global Technology Co., Ltd
With 15 years of experience in peptide synthesis, GMP compliance, and immuno‑oncology research, Dr. Chen has authored 30+ peer‑reviewed papers and served as a technical advisor for FDA‑registered vaccine programs.
Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844
© 2026 Global Technology Co., Ltd. All rights reserved.
Privacy Policy | Terms of Service | Contact Us
Trusted by Industry Leaders
CAS-90052-57-6-ACTH-(1-17) Cheap-2-bromoethyl-benzene-and-2-Bromo-1-Phenyl-Pentan-1-One Delta-MSH-peptide-supplier CAS-623172-56-5-Exenatide-Acetate
Testimonials
“The purity of the HLA‑A*0201 epitope from Global Technology allowed us to pass QC on the first run. Delivery was 2 weeks faster than any other supplier we tried.” – Dr. Michael Lee, VP R&D, ImmunoGenics (USA)
“Cost per milligram dropped by 35 % without compromising quality, enabling us to expand our neoantigen pipeline.” – Sarah Patel, Procurement Manager, BioNova Therapeutics (Canada)
Compliance & Certifications
Got questions? Find answers below →